Literature DB >> 4940295

Cable parameters, sodium, potassium, chloride, and water content, and potassium efflux in isolated external intercostal muscle of normal volunteers and patients with myotonia congenita.

R J Lipicky, S H Bryant, J H Salmon.   

Abstract

In isolated fiber bundles of external intercostal muscle from each of 13 normal volunteers and each of 6 patients with myotonia congenita, some or all of the following were measured: concentrations of Na(+), K(+), and Cl(-), extracellular volume, water content, K(+) efflux, fiber size, fiber cable parameters, and fiber resting potentials. Muscle from patients with myotonia congenita differed significantly (0.001 <P< 0.025) with respect to the following mean values (myotonia congenita vs. normal): the membrane resistance was greater (5729 vs. 2619 omega.cm(2)), the internal resistivity was less (75.0 vs. 123.2 omega.cm), the water content was less (788.2 vs. 808.2 ml/kg wet weight), and the mean resting potential was greater (68 vs. 61 mv).NO SIGNIFICANT DIFFERENCES WERE FOUND WITH RESPECT TO THE FOLLOWING VARIABLES: K(+) content (73.5 vs. 66.7 mEq/kg wet weight) and the calculated intracellular K(+) concentration (215 vs. 191 mEq/liter fiber water), fiber capacitance (5.90 vs. 5.15 muf/cm(2)), Na(+) content (97.7 vs. 94.1 mEq/kg wet weight), Cl(-) content (79.0 vs. 74.7 mEq/kg wet weight), mannitol extracellular volume (45.1 vs. 46.6 cc/100 g wet weight), and K(+) efflux (23.2 vs. 21.5 moles x 10(-12) cm(-2).sec(-1)). These abnormalities of skeletal muscle in human myotonia congenita are like those of skeletal muscle in goats with hereditary myotonia. We tentatively conclude that a decreased Cl(-) permeability accounts for some of the abnormal electrical properties of skeletal muscle in myotonia congenita.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4940295      PMCID: PMC292143          DOI: 10.1172/JCI106703

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Internal chloride concentration and chloride efflux of frog muscle.

Authors:  R H ADRIAN
Journal:  J Physiol       Date:  1961-05       Impact factor: 5.182

2.  LINEAR ELECTRICAL PROPERTIES OF STRIATED MUSCLE FIBRES OBSERVED WITH INTRACELLULAR ELECTRODES.

Authors:  G FALK; P FATT
Journal:  Proc R Soc Lond B Biol Sci       Date:  1964-04-14

3.  A study of some electrophysiological properties of human intercostal muscle.

Authors:  D ELMQVIST; T R JOHNS; S THESLEFF
Journal:  J Physiol       Date:  1960-12       Impact factor: 5.182

4.  The effect of neuromuscular blocking agents on isolated human intercostal muscles.

Authors:  R CREESE; J B DILLON; J MARSHALL; P B SABAWALA; D J SCHNEIDER; D B TAYLOR; D E ZINN
Journal:  J Pharmacol Exp Ther       Date:  1957-04       Impact factor: 4.030

5.  Conduction velocity and amplitude of the action potential as related to circumference in the isolated fibre of frog muscle.

Authors:  C H HAKANSSON
Journal:  Acta Physiol Scand       Date:  1956-07-17

6.  Membrane constants of red and white muscle fibers in the rat.

Authors:  T Kiyohara; M Sato
Journal:  Jpn J Physiol       Date:  1967-12-15

7.  Electrical properties of muscle fibre membranes in man.

Authors:  A J McComas; K Mrozek; D Gardner-Medwin; W H Stanton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-10       Impact factor: 10.154

8.  Myotonia congenita, dystrophia myotonica and paramyotonia; reaffirmation of their identity.

Authors:  O MAAS; A S PATERSON
Journal:  Brain       Date:  1950       Impact factor: 13.501

9.  Cat heart muscle in vitro. III. The extracellular space.

Authors:  E PAGE
Journal:  J Gen Physiol       Date:  1962-11       Impact factor: 4.086

10.  Sodium, potassium, and chloride fluxes in intercostal muscle from normal goats and goats with hereditary myotonia.

Authors:  R J Lipicky; S H Bryant
Journal:  J Gen Physiol       Date:  1966-09       Impact factor: 4.086

View more
  37 in total

1.  Open-label trial of ranolazine for the treatment of paramyotonia congenita.

Authors:  Samantha Lorusso; David Kline; Amy Bartlett; Miriam Freimer; Julie Agriesti; Ahmed A Hawash; Mark M Rich; John T Kissel; W David Arnold
Journal:  Muscle Nerve       Date:  2018-12-21       Impact factor: 3.217

2.  Action potentials reconstructed in normal and myotonic muscle fibres.

Authors:  R H Adrian; M W Marshall
Journal:  J Physiol       Date:  1976-06       Impact factor: 5.182

3.  Muscle cell electrical hyperpolarization and reduced exercise hyperkalemia in physically conditioned dogs.

Authors:  J P Knochel; J D Blachley; J H Johnson; N W Carter
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  Treatment of myotonia congenita with retigabine in mice.

Authors:  Chris Dupont; Kirsten S Denman; Ahmed A Hawash; Andrew A Voss; Mark M Rich
Journal:  Exp Neurol       Date:  2019-02-07       Impact factor: 5.330

5.  On the repetitive discharge in myotonic muscle fibres.

Authors:  R H Adrian; S H Bryant
Journal:  J Physiol       Date:  1974-07       Impact factor: 5.182

6.  Mammalian skeletal muscle: reduced chloride conductance in drug-induced myotonia and induction of myotonia by low-chloride solution.

Authors:  R Rüdel; J Senges
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

Review 7.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

8.  Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis.

Authors:  S C Cannon; D P Corey
Journal:  J Physiol       Date:  1993-07       Impact factor: 5.182

9.  Relaxing messages from the sarcolemma.

Authors:  Giovanni Zifarelli; Michael Pusch
Journal:  J Gen Physiol       Date:  2010-11-15       Impact factor: 4.086

10.  Relationship between membrane Cl- conductance and contractile endurance in isolated rat muscles.

Authors:  Frank Vincenzo de Paoli; Martin Broch-Lips; Thomas Holm Pedersen; Ole Bækgaard Nielsen
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.